Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines

Pigment Cell Research

Volumn 9, Issue 2, 1996, Pages 85-91

  Kichina, Julia ^a   Green, Albert ^a   Rauth, Sikha ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Department of Surgical Oncology ^*  (United States)

Author keywords

p53; Pigmentation; Repression; Tissue specific promoter; Tyrosinase gene

Indexed keywords

FELIS CATUS; ONCOVIRINAE; ROUS SARCOMA VIRUS;

CHLORAMPHENICOL ACETYLTRANSFERASE; HYBRID PROTEIN; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PROTEIN P53;

ARTICLE; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MELANOMA; METABOLISM; PIGMENTATION; PROMOTER REGION;

CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION; HUMANS; MELANOMA; MONOPHENOL MONOOXYGENASE; PIGMENTATION; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030115051     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.1996.tb00094.x     Document Type: Article

References (33)

1. Baker, S.J., Markowitz, S., Fearon, E.R., Wilson, J.K.V., and Vogelstein, B. (1990) Suppression of human colorectal carcinoma cell growth by wild type p53. Science 249:912-915.
2. Bennet, D.J. (1991) Colour genes, oncogenes, and melanocytes differentiation. J. Cell Sci. 98:135-139.
3. Bentley, N.J., Eisen, T., and Goding, C.R. (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol. Cell. Biol. 14:7996-8006.
4. Chin, K.-V., Ueda, K., Pastan, I., and Gottesman, M.M. (1993) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459-462.
5. Datta, P.K., and Bagchi, S. (1994) Repression of transforming growth factor β promoter by the adenovirus oncogene E1A. J. Biol. Chem. 269:25392-25399.
6. Dooley, T.P., Wilson, R.E., Jones, N.C., and Hart, I.R. (1988) Polyoma middle T abrogates TPA requirement of murine melanocytes and induces malignant melanoma. Oncogene 3:531-535.
7. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
8. Gnass, R., Schutz, G., and Beermann, F. (1994) The mouse tvrosinase gene. J. Biol. Chem. 269:29808-29816.
9. Ginsberg, D., Mecheta, F., Yaniv, M., and Oren, M. (1991) Wild type p53 can down modulate the activity of various promoters. Proc. Natl. Acad. Sci. U.S.A. 88:4570-4571.
10. Kastan, M.B., Onyerkwere, O., Sidransky, D., Vogelstein, B., and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 53:6304-6311.
11. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, B., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace, A.J. (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD 45 is defective in atoxia-telengiectasia. Cell 71:587-597.
12. Kern, S.E., Peterpal, J.A., Thiagalingan, S., Seymour, A., Kinxlzer, K.W., and Vogelstein, B. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-8830.
13. Kluppel, M., Beerman, F., Ruppert, S., Schmid, E., Hummler, E., and Schutz, G. (1991) The mouse tyrosinase promoter is sufficient for expression in melanocytes and in the pigmented epithelium of the retina. Proc. Natl. Acad. Sci. U.S.A. 88:3777-3781.
14. Liu, X., Miller, C.W., Koeffler, P.H., and Berk, A.J. (1993) The p53 activation domain binds the TATA box-binding polypeptide in HoloTFII D and a neighboring p53 domain inhibits transcription. Mol. Cell Biol. 13:3291-3300.
15. Lu, X., and Lane, D.P. (1993) Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosome instability syndromes? Cell 75:765-778.
16. Mack, D.H., Vartikar, J., Pipas, J.M., and Laiminis, L.A. (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild type p53. Nature 363:281-281.
17. Miyashita, T., Harigai, M., Kanada, M., and Reed, J.C. (1994) Identification of p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:3131-3135.
18. Morello, D., Duprey, P., Israel, A., Babinet, C. (1990) A synchronous regulation of mouse H-2D and β2-microglobulin RNA transcripts. Immunogenetics 22:441-452.
19. Noonan, K.E., Beck, T.A., Holzmayer, J.E., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D.D., and Roninson, I.B. (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 87:7160-7164.
20. Pomerantz, S.H. (1964) Tyrosine hydroxylation catalyzed by mammalian tyrosine: An improved method of assay. Biochem. Biophys. Res. Commun. 16:188-194.
21. Ponnazhagan, S., Hou-L., Kwon, B.S. (1994) Structural organization of the human tyrosinase gene and sequence analysis and characterization of its promoter region. J. Invest. Dermatol. 102:744-748.
22. Powers, T.P., Shows, T.B., and Davidson, R.L. (1994) Pigment-cell specific genes from fibroblasts are transactivated after chromosomal transfer into melanoma cells. Mol. Cell Biol. 14:1179-1190.
23. Rauth, S., Hoganson, G.E., and Davidson, R.L. (1990a) Bromodeoxyuridine-and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells. Somatic Cell Mol. Genet. 16(6):583-592.
24. Rauth, S., Yang, K.G., Siebold, A., Ingolia, D., Ross, S., and Yeung, C. (1990b) GC-rich murine adenosine deaminase gene promoter supports diverse tissue specific gene expression. Somatic Cell Mol. Genet. 16(2):129-141.
25. Rauth, S., and Davidson, R.L. (1993) Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of tyrosinase gene. Somatic Cell Mol Genet. 19(3):285-293.
26. Rauth, S., Green, A., Bratescu, L., and Das Gupta, T.K. (1994a) Chromosome abnormalities in metastatic melanoma. In Vitro Cell. Dev. Biol. Animal 30A(2):79-84.
27. Rauth, S., Kichina, J., Green, A., Bratescu, L., and Das Gupta, T.K. (1994b) Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice. Anticancer Res. 14(6):2457-2464.
28. Scharer, E., and Iggo, R. (1992) Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res. 20:1539-1545.
29. Silagi, S., and Bruce, S.A. (1970) Suppression of malignancy and differentiation in melanotic melanoma cells. Proc. Natl. Acad. Sci. U.S.A. 66:72-78.
30. Unger, T., Nau, M.M., Segal, S., and Olinna, J.D. (1992) Functional domains of wild type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition and transformation suppression. EMBO J. 11:1383-1390.
31. Vogelstein, B., and Kinzler, K.W. (1992) p53 function and dysfunction. Cell 70:523-526.
32. Wilson, R.E., Dooley, T.P., and Hart, I.R. (1989) Transfection of murine melanocytes with v-Ha-ras induces tumorigenicity and overcomes in vitro growth requirement for 12-0-tetradecanoyl-phorbol 13-acetate. Cancer Res. 49:711-716.
33. Zhang, W., Funk, W.D., Wright, W.E., Shay, J.W., Deisseroth, A.B. (1993) Novel binding of p53 mutants and their role in transcriptional activation. Oncogene, 8:2555-2559.